Cittadine Andrew Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$149,658.05
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Cittadine Andrew

Biography of Cittadine Andrew

No biography is available at this moment.

2024-06-20PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
20,508
0.107%
$0.74$15,254+609.94%
2024-06-18PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0724%
$0.86$10,320+475.36%
2024-06-17PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0758%
$0.90$10,799+451.05%
2024-06-14PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0784%
$0.93$11,176+392.98%
2024-06-13PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0766%
$0.91$10,920+404.92%
2024-06-04PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0696%
$0.78$9,360+473.05%
2024-06-03PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0678%
$0.76$9,120+464.94%
2024-05-31PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0724%
$0.64$7,732+586.27%
2024-05-30PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0717%
$0.64$7,676+581.37%
2024-05-29PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
12,000
0.0705%
$0.64$7,643+558.06%
2022-11-15PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
10,000
0.0881%
$3.15$31,500-66.05%
2022-11-14PurchaseMonopar Therapeutics Inc.
MNPR
Chief Operating Officer
6,053
0.0462%
$3.00$18,159-68.93%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.